Catalyst Wire Dossier Catalyst Wire Dossier

DE-117

· Santen Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DE-117, covering 2017-11-20 to 2024-03-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT [Phase 3]

See pricing